Kubient Q3 EPS $(0.16) Beats $(0.24) Estimate, Sales $677.00K Beat $600.00K Estimate
Kubient (NASDAQ:KBNT) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.24) by 33.33 percent. This is a 84.47 percent increase over losses of $(1.03) per share from the same
Earnings Scheduled For November 10, 2021
Companies Reporting Before The Bell
• LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million.
38 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Triple-S Management Corporation (NYSE: GTS) shares jumped 45.3% to $35.15. GuideWell Mutual Holding Corporation, parent of Blue Cross and Blue Shield of Florida Inc, will acquire Triple-S Management for an equity value of approximately $900 million.
66 Biggest Movers From Yesterday
Gainers
Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares surged 265.5% to close at $15.35 on Tuesday after the company received a written pre-investigational new drug (pre-IND) response from the FDA regarding MMS019.
Mid-Afternoon Market Update: Dow Tumbles Over 400 Points; Virpax Pharmaceuticals Shares Spike Higher
Toward the end of trading Tuesday, the Dow traded down 1.18% to 35,204.03 while the NASDAQ fell 1.24% to 14,610.77. The S&P also fell, dropping 1.06% to 4,432.01.
Mid-Day Market Update: monday.com Jumps Following Strong Q2 Results; Kubient Shares Plunge
Midway through trading Tuesday, the Dow traded down 0.81% to 35,336.88 while the NASDAQ fell 0.89% to 14,661.86. The S&P also fell, dropping 0.65% to 4,450.54.
48 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares jumped 93% to $$8.10 after the company received a written pre-investigational new drug (pre-IND) response from the FDA regarding MMS019.
Mid-Morning Market Update: Markets Open Lower; Walmart Profit Tops Estimates
Following the market opening Tuesday, the Dow traded down 0.67% to 35,385.44 while the NASDAQ fell 0.79% to 14,676.74. The S&P also fell, dropping 0.54% to 4,455.32.